Is Lancet Oncology Indexed in PubMed? Yes, and MEDLINE Is Active
The Lancet Oncology is indexed in PubMed and currently indexed for MEDLINE, which matters because top oncology papers need broad clinical and translational visibility.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: yes. The Lancet Oncology is indexed in PubMed, and the NLM Catalog shows that it is currently indexed for MEDLINE.
Direct answer
If you publish in The Lancet Oncology, your article is discoverable in PubMed and the journal sits inside the active MEDLINE system.
The NLM record shows:
- publication start year: 2000
- PubMed coverage from volume 1, issue 1 (September 2000)
- MEDLINE coverage from volume 1, issue 1 (September 2000)
- current indexing status: Currently indexed for MEDLINE
- current subset: Index Medicus
That is a strong, straightforward indexing record for a top oncology journal.
Why this matters for Lancet Oncology
Strong Lancet Oncology papers often want to reach:
- clinical oncologists
- trialists and disease-group leaders
- translational cancer researchers
- guideline and review authors
Those readers often search by disease, endpoint, therapy, biomarker, or trial question rather than by browsing one journal issue. PubMed indexing matters because it helps the paper move through those real oncology search workflows.
PubMed versus MEDLINE
For this journal, the distinction remains useful:
- PubMed means the paper is discoverable in the main biomedical search system.
- MEDLINE means the journal is actively inside the curated NLM journal index.
For a high-stakes oncology journal, that combination matters because the strongest papers are supposed to shape practice, reviews, and broad field interpretation.
What indexing does and does not tell you
This page answers the discoverability question. It does not answer whether the manuscript is consequential enough or broad enough for The Lancet Oncology.
Indexing tells you the paper will be visible. It does not tell you whether the work has enough oncology consequence, rigor, or breadth for the journal’s actual editorial bar.
That is why the better next reads are:
- Is Lancet Oncology a good journal?
- Lancet Oncology submission guide
- Lancet Oncology submission process
- Lancet Oncology acceptance rate
Practical verdict
Yes, The Lancet Oncology is indexed in PubMed and currently indexed for MEDLINE. If your question is whether a published paper will be visible in the main oncology search workflow, the answer is yes.
If your real question is whether the manuscript deserves a Lancet Oncology audience rather than a narrower oncology venue, that is a separate fit judgment. A free Manusights scan is the best next step if you want that call before submission.
Sources
- 1. The Lancet Oncology NLM Catalog record, NLM.
- 2. NLM Catalog help: current indexing status, NLM.
- 3. The Lancet Oncology homepage, Elsevier.
- 4. The Lancet Oncology information for authors, Elsevier.
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.